Typically once weekly, though some protocols use twice-weekly dosing
The initial dose is low, and your doctor may adjust it after one week
Retention of this unmodified histidine in retatrutide preserves potent glucagon receptor agonism, which is a defining structural distinction compared to tirzepatide, where this position is also histidine but the molecule lacks meaningful glucagon receptor activity due to other sequence differences
DTNB is a highly selective probe specific to thiol groups
So by far, these injectables are the most appropriate for people who have heart disease or polypharmacy, meaning they take a long list of medications
Many people start these medications expecting quick results, but the timeline can be different for everyone